Docket Number:28A-1031129
Inventor:Rong-Jie Chein、Klim King
IP Status:TW I594991、PCT pending
Abstract:
Novel glucagon-like peptide-1 (GLP-1) modulators are used for the treatment and prophylaxis of diseases and disorders associated with hyperglycemia.
Fields of Application:
anti-diabetes
Advantages when compared to the existing technologies:
It can be synthesized in large quantities of the natural active ingredient.
Contact Person:
對本技術有興趣,請於本處網頁廠商選項下(廠商需求與諮詢)網頁填寫資料,承辦人將跟您聯絡。
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Apply for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office, and the undertaker will contact you
